BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kohli MA, Maschio M, Mould-Quevedo JF, Ashraf M, Drummond MF, Weinstein MC. The Cost-Effectiveness of Expanding Vaccination with a Cell-Based Influenza Vaccine to Low Risk Adults Aged 50 to 64 Years in the United Kingdom. Vaccines (Basel) 2021;9:598. [PMID: 34199912 DOI: 10.3390/vaccines9060598] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Jiang S, Wang Y, Si L, Zang X, Gu YY, Jiang Y, Liu GG, Wu J. Incorporating productivity loss in health economic evaluations: a review of guidelines and practices worldwide for research agenda in China. BMJ Glob Health 2022;7:e009777. [PMID: 35977755 DOI: 10.1136/bmjgh-2022-009777] [Reference Citation Analysis]
2 Boikos C, Mcgovern I, Molrine D, Ortiz JR, Puig-barberà J, Haag M. Review of Analyses Estimating Relative Vaccine Effectiveness of Cell-Based Quadrivalent Influenza Vaccine in Three Consecutive US Influenza Seasons. Vaccines 2022;10:896. [DOI: 10.3390/vaccines10060896] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Hoang U, Delanerolle G, Fan X, Aspden C, Byford R, Ashraf M, Haag M, Elson W, Leston M, Anand S, Ferreira F, Joy M, Hobbs R, de Lusignan S. A Profile of Influenza Vaccine Coverage for 2019-2020: a Database Study of the English Primary Care Sentinel Cohort (Preprint).. [DOI: 10.2196/preprints.39297] [Reference Citation Analysis]
4 Maschio M, Kohli MA, Ashraf M, Drummond MF, Weinstein MC, Mould-quevedo JF. An Economic Comparison of Influenza Vaccines Recommended for Use in Eligible Adults under 65 Years in the United Kingdom. Vaccines 2022;10:599. [DOI: 10.3390/vaccines10040599] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kohli MA, Maschio M, Mould-Quevedo JF, Drummond M, Weinstein MC. The cost-effectiveness of an adjuvanted quadrivalent influenza vaccine in the United Kingdom. Hum Vaccin Immunother 2021;:1-8. [PMID: 34550848 DOI: 10.1080/21645515.2021.1971017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]